Drug Topics
JUNE 13, 2024
Patrick Alonso, PharmD, CPh, discusses how pharmacists can support men dealing with mental health issues and lifestyle changes he recommends to male patients to improve overall health.
Pharmacy Times
JUNE 13, 2024
The autoinjector will provide another option for adults in addition to the prefilled syringe that is currently available.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 13, 2024
In a world rich with diversity, pharmacists need to understand how varied backgrounds and special needs can impact a patient’s decisions in managing their health and medication protocols.
Pharmacy Times
JUNE 13, 2024
The SCDM model demands more than the traditional roles assigned to pharmacists, requiring an enhanced level of patient engagement, medical knowledge, and legal authority to implement effectively
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JUNE 13, 2024
The therapy from AstraZeneca is indicated to improve glycemic control in patients aged 10 years or older.
STAT
JUNE 13, 2024
LONDON — Seth Berkley, a longtime and widely respected global health leader , said Thursday that it has been “shocking to watch the ineptitude” of the U.S. response to the avian influenza outbreak among dairy cattle , adding his voice to a chorus of critics. In a presentation in London about vaccine development, Berkley, the former CEO of Gavi, the Vaccine Alliance, raised the issue of H5N1 bird flu when discussing whether the world was ready for another pandemic following i
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JUNE 13, 2024
The U.S. Department of Agriculture released two reports Thursday that lay out what has been learned about how H5N1 bird flu is moving among dairy cow herds in the United States. The reports do not shed much new light on the situation. Instead, they sum up what is known: that the outbreak was probably the result of a single “spillover” of the virus from wild birds into a dairy herd, likely late last year, and that movement of cows, farmworkers, and shared equipment appears to be res
Drug Topics
JUNE 13, 2024
Sponsored Content: Step-by-step instructions for pharmacy staff to enroll eligible patients in the Tyrvaya Savings Offer to reduce out-of-pocket costs.
STAT
JUNE 13, 2024
Early in her pregnancy in 2015, Nicole Hashemi wanted to know how much caffeine was safe for her to consume. “I was actually advised not to drink a lot of caffeine,” Hashemi, an associate professor of mechanical engineering at Iowa State University, told STAT. The American College of Obstetrics and Gynecologists, for instance, advises that pregnant people consume no more than 200 milligrams per day to reduce the risk of miscarriage or preterm birth.
Drug Topics
JUNE 13, 2024
Sponsored Content: A pharmacist counsels a newly prescribed Tyrvaya patient on how Tyrvaya nasal spray works, adverse effects, administration technique, and how to access available resources.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
European Pharmaceutical Review
JUNE 13, 2024
Tell us about Ocugen’s lead programme, OCU400. What’s the latest and what’s next? OCU400 is a modifier gene therapy aimed at treating retinitis pigmentosa and Leber congenital amaurosis (LCA). In April 2024, Ocugen received US Food and Drug Administration (FDA) clearance to initiate the Phase III liMeliGhT clinical trial for OCU400 for retinitis pigmentosa.
Drug Topics
JUNE 13, 2024
The APhA urged policy makers to consider these recommendations to avoid further exacerbating effects of the attack on US health systems.
STAT
JUNE 13, 2024
LONDON — A major shakeup in how the benefits of medicines are assessed in Europe is looming, and developers of treatments like gene therapies are already arguing that what they see as flaws in the new system could entrench the issues they’ve had getting their products to patients. Starting next year, there will be a new, continent-level review of a drug’s effectiveness compared to what else is on the market.
Pharmacy Times
JUNE 13, 2024
Anti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JUNE 13, 2024
The day an FDA advisory committee met to weigh the merits of an experimental treatment for amyotrophic lateral sclerosis was one of the worst of Mitze Klingenberg’s life. Her son Matt had benefited, she said, from an ALS treatment under review for approval by the Food and Drug Administration. However, the expert panel voted against the therapy on that day, Sept. 27, 2023.
PharmaVoice
JUNE 13, 2024
Kenneth Mills will become chair of the gene therapy developer's board while Curran Simpson, the current chief operating officer, will take his place as company head.
STAT
JUNE 13, 2024
The CEO and clinical president of a closely watched telehealth startup prescribing ADHD-medication Adderall online have been arrested and charged with fraud, the Justice Department announced today. Done founder Ruthia He, and clinical president David Brody, were arrested in Los Angeles and San Rafael, California respectively. They were charged with allegedly taking part in a scheme to distribute controlled substances online and submitting false and fraudulent reimbursement claims for stimulant p
PharmaVoice
JUNE 13, 2024
Lilly is the latest to approach the coveted Alzheimer’s approval, but a slate of drugmakers are lining up clinical trials in amyloid and tau to take a shot at improving patient outcomes.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JUNE 13, 2024
“In Sweeping War on Obesity, Chile slays Tony the Tiger.” So read the headline of a front-page story in The New York Times in 2018 on a dramatic step Chile was taking to fight obesity. With some of the highest obesity levels in South America, the country had begun enforcing strict regulations on Frosted Flakes and other foods that exceeded set thresholds for sugar, calories, salt, or saturated fat in 2016.
Fierce Healthcare
JUNE 13, 2024
The Centers for Medicare & Medicaid Services (CMS) appears poised to rework Medicare Advantage (MA) quality ratings for this year, The Wall Street Journal
Pharmacy Times
JUNE 13, 2024
Listen closely and ask clarifying questions to best address patient challenges.
Fierce Healthcare
JUNE 13, 2024
The CEO and clinical president of telehealth startup Done have been arrested and charged with fraud, accused by federal authorities of participating in a scheme to distribute Adderall online. | According to the DOJ, Done's CEO and clinical president allegedly arranged the prescription of 40 million Adderall pills as well as other stimulants, generating more than $100 million in revenue.
Pharmacy Times
JUNE 13, 2024
The awards were announced last night at the ABA gala held at the Marriott Marquis in New York City.
Fierce Healthcare
JUNE 13, 2024
There have been many twists and turns in Decent Health's six-year journey as a startup. | Decent has relaunched with a new approach to build level-funded health plans around direct primary care to serve small and medium-sized companies.
STAT
JUNE 13, 2024
On this week’s episode of “The Readout LOUD,” our STAT colleague Nicholas Florko joins us to explain what it means to be a reporter who writes about the commercial determinants of health. Hint: Florko’s most recent stories focused on weed, vapes and raw milk. And instead of being chained to a desk, he often drives around to convenience stores and buy bad stuff — all in the name of good journalism.
Fierce Healthcare
JUNE 13, 2024
Blue Cross Blue Shield of Michigan will pull back on coverage for GLP-1 drugs amid rising costs for these products. | Blue Cross Blue Shield of Michigan will pull back on coverage for GLP-1 drugs amid rising costs for these products.
pharmaphorum
JUNE 13, 2024
Explore the key moments of truth in launch excellence for MSLs and commercial teams in this informative white paper. Gain valuable insights and strategies for successful launches.
The FDA Law Blog
JUNE 13, 2024
By Sara W. Koblitz — As we have noted for the last year or so, the FTC has been on a mission to clean up the Orange Book by removing what it deems to be “improper” patents. The FTC has put out policy statements, challenged patent listings, tapped Congress, appeared on talk shows, and filed amicus briefs all in the span of the last 8 months. It seems like all that work is paying off.
pharmaphorum
JUNE 13, 2024
Learn valuable marketing lessons for B2B pharma companies by examining successful strategies used in the B2C prescription market, including over-the-counter (OTC) products and interactions with healthcare professionals (HCPs).
Fierce Healthcare
JUNE 13, 2024
The California Public Employees’ Retirement System (CalPERS) has named Blue Shield of California as the only health plan in its preferred provider organization.
pharmaphorum
JUNE 13, 2024
Mahana Therapeutics has granted permanent reimbursement in Germany for its Cara Care digital therapeutic for irritable bowel syndrome
The Checkup by Singlecare
JUNE 13, 2024
Meloxicam , brand name Metacam, is a prescription medication that falls into the class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). The U.S. Food and Drug Administration (FDA) approves meloxicam for managing pain and inflammation in cats and dogs in veterinary medicine. “In dogs, meloxicam is prescribed primarily to relieve pain and inflammation associated with osteoarthritis (joint pain), neurological disease, or to alleviate discomfort after surgery,” says Mat Glassman, MB
pharmaphorum
JUNE 13, 2024
Pfizer is “evaluating next steps” for its Duchenne muscular dystrophy (DMD) gene candidate after it failed a phase 3 trial
Expert insights. Personalized for you.
503 
Let's personalize your content